This study investigated the relationship between thyroid autoantibodies—thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb)—and metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM). Here, TG is linked to diabetes mellitus.